These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5910040)

  • 1. A method for preparing plasma factor 8 (antihemophilic globulin) concentrate.
    Simson LR; Oberman HA; Penner JA; Lien DM; Warner CL
    Am J Clin Pathol; 1966 Apr; 45(4):373-6. PubMed ID: 5910040
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation and testing of antihemophilic globulin (Factor 8) sources for transfusion therapy in hemophilia. Description of a new sterile concentrate process for blood banks.
    Pool JG
    Scand J Clin Lab Invest; 1965; 17():Suppl 84:70-7. PubMed ID: 5862567
    [No Abstract]   [Full Text] [Related]  

  • 3. Factor VIII concentrates made in the United Kingdom and the treatment of haemophilia based on studies made during 1969--72. Report of the Medical Research Council's Blood Transfusion Research Committee Working Party on the cryoprecipitate method of preparing AHF concentrates.
    Br J Haematol; 1974 Jul; 27(3):391-405. PubMed ID: 4413414
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modification of J.G. Pool's technic for the production of cryoprecipitates with highly concentrated antihemophilic globulin (factor 8) content. I].
    Wegner H; Bergmann A
    Z Gesamte Inn Med; 1967 Jul; 22(13):389-92. PubMed ID: 5592690
    [No Abstract]   [Full Text] [Related]  

  • 5. The potent antihemophilic globulin concentrate derived from a cold insoluble fraction of human plasma: characterization and further data on preparation and clinical trial.
    Hershgold EJ; Pool JG; Pappenhagen AR
    J Lab Clin Med; 1966 Jan; 67(1):23-32. PubMed ID: 5321736
    [No Abstract]   [Full Text] [Related]  

  • 6. [HEMOSTATIC TRANSFUSION PREPARATIONS PREPARED FROM DONOR BLOOD (ANTIHEMOPHILIC PLASMA, ANTIHEMOPHILIC GLOBULIN, FIBRINOGEN)].
    ROZENBERG GIa; RUDNITSKAIA MZ
    Probl Gematol Pereliv Krovi; 1963 Jun; 8():3-9. PubMed ID: 14070543
    [No Abstract]   [Full Text] [Related]  

  • 7. Glycine-precipitated antihemophilic factor concentrates and their clinical use.
    Wagner RH; Roberts HR; Webster WP; Shanbrom E; Brinkhous KM
    Thromb Diath Haemorrh Suppl; 1968; 35():41-8. PubMed ID: 5761073
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of donor characteristics and preparation methods on the potency of human cryoprecipitate.
    Burka ER; Puffer T; Martinez J
    Transfusion; 1975; 15(4):323-8. PubMed ID: 1166505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The dosage of antihemophilic globulin, or antihemophilic plasma as well as Cohn's fraction I in factor VIII deficiency].
    Hrubisková K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):363-8. PubMed ID: 4195283
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of lyophilized plasma as a reference sample for determining factor VIII].
    Tarasova LN; Platonova GK; Starkova EV
    Lab Delo; 1991; (2):43-6. PubMed ID: 1709986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of stable lyophilized cryoprecipitate in the original frozen plasma bags.
    Margolis J; Eisen M
    Vox Sang; 1986; 50(1):38-41. PubMed ID: 3082076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor plasmapheresis and regional self sufficiency.
    Urbaniak SJ
    Int J Artif Organs; 1984 Jan; 7(1):43-6. PubMed ID: 6421755
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental indication of the existence of 2 forms of antihemophilic globulin A (factor VIII)].
    Liebe S; Wegner H; Bergmann A
    Z Gesamte Inn Med; 1972 Feb; 27(3):128-30. PubMed ID: 5024244
    [No Abstract]   [Full Text] [Related]  

  • 14. [The cryoprecipitate, plasmatic fraction rich in antihemophilic globulin (factor VIII). Its use in the treatment of hemophilia].
    Otto-Servais M; Hugues J
    Rev Med Liege; 1969 May; 24(10):401-7. PubMed ID: 5376503
    [No Abstract]   [Full Text] [Related]  

  • 15. [Analysis of the antihemophilic globulin A (factor VIII) in cryoprecipitates using chromatography and polyacrylamide gel electrophoresis].
    Liebe S; Diezel W; Wegner H
    Z Gesamte Inn Med; 1972 Feb; 27(3):125-8. PubMed ID: 5024243
    [No Abstract]   [Full Text] [Related]  

  • 16. Dry-heat treatment process for enhancing viral safety of an antihemophilic factor VIII concentrate prepared from human plasma.
    Kim IS; Choi YW; Kang Y; Sung HM; Shin JS
    J Microbiol Biotechnol; 2008 May; 18(5):997-1003. PubMed ID: 18633304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Substitution of antihemophilic globulin (factor VIII) with special reference to Pool's cold fractionation].
    Matthes M; Engbring H; Winckelmann G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(4):434-40. PubMed ID: 4107580
    [No Abstract]   [Full Text] [Related]  

  • 18. [Electrophoretic studies of human plasma cryoprecipitates with a high content of antihemophilic globulin A].
    Kleint V; Wegner H
    Z Gesamte Inn Med; 1970 Apr; 25(7):312-4. PubMed ID: 5521442
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood and neoplastic diseases. Haemophilia and related disorders.
    Rizza CR
    Br Med J; 1974 Oct; 4(5935):36-8. PubMed ID: 4547674
    [No Abstract]   [Full Text] [Related]  

  • 20. Some complications of the therapy of classic hemophilia.
    Ratnoff OD
    J Lab Clin Med; 1984 May; 103(5):653-9. PubMed ID: 6425440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.